Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when Artiva Biotherapeutics, Inc. publishes a filing, an earnings call transcript or a press release.

Get ARTV alerts

About Jennifer Bush

Jennifer Bush is recorded as COO at Artiva Biotherapeutics, Inc. (ARTV) and Board Member at Century Aluminum Co (CENX) since January 1, 2021. The newest filing on record that lists Jennifer Bush as COO at Artiva Biotherapeutics, Inc. (ARTV) is dated August 3, 2026. The newest filing on record that lists Jennifer Bush as Board Member at Century Aluminum Co (CENX) is dated April 24, 2026. The proxy statement of Artiva Biotherapeutics, Inc. reports total compensation of $1,536,715 for Jennifer Bush in fiscal 2025, including a base salary of $520,000. Disclosed compensation is on record for 2 fiscal years. Artiva Biotherapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Century Aluminum Co is classified in the Aluminum industry within the Basic Materials sector. Other leadership on record at Artiva Biotherapeutics, Inc. includes Fred Aslan (CEO and Board Member), Fred Aslan, M.D. (CFO), Neha Krishnamohan (CFO) and 7 others.

Affiliation history

Company network

Leadership on record at Artiva Biotherapeutics, Inc.

Leadership on record at Century Aluminum Co

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Artiva Biotherapeutics, Inc. (ARTV) $520,000 $1,536,715
2024 Artiva Biotherapeutics, Inc. (ARTV) $478,194 $1,505,839

Recent activity

No call appearances or filed executive changes recorded yet.